BUYSE, Marc

Email Alert RSS Feed

Profile

Full Name
BUYSE, Marc
Email
marc.buyse@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Results 141-160 of 216 (Search time: 0.025 seconds).

show all
Issue DateTitleContributor(s)TypeCat.
1412005A meta-analytic validation framework for continuous outcomesMOLENBERGHS, Geert; BUYSE, Marc; BURZYKOWSKI, TomaszBook SectionB2
1422005Fraud detectionBUYSE, MarcBook SectionB3
1432005Multicenter trialsBUYSE, MarcBook SectionB3
1442005The history of surrogate endpoint validationMOLENBERGHS, Geert; BUYSE, Marc; BURZYKOWSKI, TomaszBook SectionB2
1452005A quantitative study of tumor response and progression-free survival as surrogate endpoints for overall survival in first-line treatment of metastatic breast cancerBURZYKOWSKI, Tomasz; Piccart, MJ; Sledge, G; Carmichael, J; Luck, HJ; Mackey, John R.; Nabholtz, JM; Paridaens, R; Biganzoli, L; Jassem, J; Blohmer, JU; Bontenbal, M; Bonneterre, J; Chan, S; Atalay, G.; Therasse, P; BUYSE, MarcJournal ContributionM
1462005Effects of taxanes alone or in combination with anthracyclines on tumor response, progression-free survival and overall survival in first-line chemotherapy of patients with metastatic breast cancer: an analysis of 4,256 patients randomized in 12 trialsPiccart, MJ; BURZYKOWSKI, Tomasz; Sledge, G; Luck, HJ; Mackey, John R.; Nabholtz, JM; Paridaens, R; Biganzoli, L; Jassem, J; Blohmer, JU; Bontenbal, M; Bonneterre, J; Chan, S; Atalay, G.; Carmichael, J; BUYSE, Marc; Therasse, PJournal ContributionM
1472004Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: an updated meta-analysisBUYSE, Marc; et alJournal ContributionA1
1482004Prentice's approach and the meta-analytic paradigm: a reflection on the role of statistics in the evaluation of surrogate endpointsALONSO ABAD, Ariel; MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; RENARD, Didier; GEYS, Helena; SHKEDY, Ziv; TIBALDI, Fabian; CORTINAS ABRAHANTES, Jose; BUYSE, MarcJournal ContributionA1
1492004FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR studyTournigand, Christophe; André, Thierry; Achille, Emmanuel; Lledo, Gérard; Flesh, Michel; Mery-Mignard, Dominique; Quinaux, Emmanuel; Couteau, Corinne; BUYSE, Marc; Ganem, Gérard; Landi, Bruno; Colin, Philippe; Louvet, Christophe; de Gramont, AimeryJournal ContributionA1
1502004A perspective on surrogate endpoints in controlled clinical trialsMOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; ALONSO ABAD, Ariel; BUYSE, MarcJournal ContributionA1
1512004Efficacy of oral adjuvant therapy after resection of colorectal cancer: 5-year results from three randomized trialsSakamoto, J.; Ohashi, Y.; Hamada, C.; BUYSE, Marc; BURZYKOWSKI, Tomasz; Piedbois, P.Journal ContributionA1
1522004The validation of surrogate endpoints by using data from randomized clinical trials: a case-study in advanced colorectal cancerBURZYKOWSKI, Tomasz; MOLENBERGHS, Geert; BUYSE, MarcJournal ContributionA1
1532003Comparaison entre LV5FU2 bi-mensuel et FUFOL mensuel pendant 24 ou 36 semaines en traitement adjuvant des cancers du colon stade II et III: résultats à 4 ans d'une étude randomiséeBUYSE, Marc; André, Thierry; Artru, P.; Gamelin, E.; Bouche, O.; Achille, Emmanuel; Piedbois, P.; Flesch, M.; Tubiana-Mathieu, N.; de Gramont, A.Journal ContributionA2
1542003Simplified hierarchical linear models for the evaluation of surrogate endpointsTIBALDI, Fabian; CORTINAS ABRAHANTES, Jose; MOLENBERGHS, Geert; RENARD, Didier; BURZYKOWSKI, Tomasz; BUYSE, Marc; Parmar, Mahesh; Stijnen, Theo; Wolfinger, RussJournal ContributionA1
1552003Using the 'expected' survival to explain differences between the results of randomized trials: a case in advanced ovarian cancerBUYSE, Marc; BURZYKOWSKI, Tomasz; Parmar, Mahesh; Torri, Valter; Omura, George; Colombo, Nicoletta; Williams, Chris; Conte, Pierfranco; Vermorken, JanJournal ContributionA1
1562003Overall survival is not a realistic endpoint for clinical trials in advanced solid tumors: a critical assessment based on recently reported phase III trials in colorectal and breast cancerDi Leo, A.; Bleiberg, H.; BUYSE, MarcJournal ContributionA1
1572003Validation of biomarkers as surrogates for clinical endpointsBUYSE, Marc; VANGENEUGDEN, Tony; BIJNENS, Luc; RENARD, Didier; BURZYKOWSKI, Tomasz; GEYS, Helena; MOLENBERGHS, GeertBook SectionB3
1582003Validation of a longitudinally measured surrogate for a time-to-event endpointRENARD, Didier; GEYS, Helena; MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; BUYSE, Marc; VANGENEUGDEN, Tony; BIJNENS, LucJournal ContributionA1
1592003Semimonthly Versus Monthly Regimen of Fluorouracil and Leucovorin Administered for 24 or 36 Weeks as Adjuvant Therapy in Stage II and III Colon Cancer: Results of a Randomized TrialBUYSE, Marc; André, Thierry; Colin, P.; Liouvet, C.; Gamelin, E.; Bouche, O.; Achille, Emmanuel; Colbert, N.; Boaziz, C.; Piedbois, P.; Tubiana-Mathieu, N.; Boutan-Laroze, A.; Flesch, M.; Billau, V.; de Gramont, A.Journal ContributionA1
1602002Challenges in the methodology for the validation of surrogate endpoints in randomized trialsMOLENBERGHS, Geert; BUYSE, Marc; GEYS, Helena; RENARD, Didier; BURZYKOWSKI, TomaszProceedings PaperC2
show all